Crinetics Pharmaceuticals Inc. Common Stock (CRNX)

Stock · NASDAQ · Health Care

$84.84as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$84.12

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

CRNX
Crinetics Pharmaceuticals Inc. Common Stock
$84.84
▼ 0.01%
Market cap $8.90BP/E —
SYRE
Spyre Therapeutics Inc. Common Stock
$90.4
▼ 3.43%
Market cap $9.12BP/E —
$14.51$110.18
PTGX
Protagonist Therapeutics Inc. Common Stock
$144.15
▼ 3.58%
Market cap $9.40BP/E —
RYTM
Rhythm Pharmaceuticals Inc. Common Stock
$107.23
▼ 4.71%
Market cap $7.72BP/E —
CYTK
Cytokinetics Incorporated Common Stock
$72.17
▼ 7.36%
Market cap $10.13BP/E —
$35.22$88.31
TGTX
TG Therapeutics Inc. Common Stock
$53.91
▼ 3.25%
Market cap $7.59BP/E —
PRAX
Praxis Precision Medicines Inc. Common Stock
$344.95
▼ 6.23%
Market cap $10.32BP/E —

Symbol	Market cap	P/E ratio	Price	1D	52-week range
CRNX Crinetics Pharmaceuticals Inc. Common Stock	$8.90B	—	$84.84	▼ 0.01%
SYRE Spyre Therapeutics Inc. Common Stock	$9.12B	—	$90.4	▼ 3.43%	$14.51$110.18
PTGX Protagonist Therapeutics Inc. Common Stock	$9.40B	—	$144.15	▼ 3.58%
RYTM Rhythm Pharmaceuticals Inc. Common Stock	$7.72B	—	$107.23	▼ 4.71%
CYTK Cytokinetics Incorporated Common Stock	$10.13B	—	$72.17	▼ 7.36%	$35.22$88.31
TGTX TG Therapeutics Inc. Common Stock	$7.59B	—	$53.91	▼ 3.25%
PRAX Praxis Precision Medicines Inc. Common Stock	$10.32B	—	$344.95	▼ 6.23%

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.